In conclusion, the prognostic score model based on N classification, pretreatment plasma EBV DNA, platelet count and serum albumin provides a useful method of selecting patients with locoregionally advanced NPC who may benefit from more intensive treatment. The gene discussed is ALB; the disease is nasopharyngeal carcinoma.